New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials
07.09.2022 - IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced new evidence that decentralized clinical trials (DCT) deliver measurable benefits ...
Source: wallstreet-online.de